Breaking News Instant updates and real-time market news.

NBRV

Nabriva Therapeutics

$2.04

-0.035 (-1.69%)

04:55
02/20/19
02/20
04:55
02/20/19
04:55

Nabriva Therapeutics management to meet with Morgan Stanley

Meeting to be held in New York on February 20 hosted by Morgan Stanley.

  • 20

    Feb

  • 30

    Apr

  • 19

    Aug

NBRV Nabriva Therapeutics
$2.04

-0.035 (-1.69%)

08/27/18
BOFA
08/27/18
NO CHANGE
Target $5
BOFA
Buy
Nabriva Therapeutics price target lowered to $5 from $9 at BofA/Merrill
BofA/Merrill analyst Jason Gerberry lowered his price target on Nabriva Therapeutics to $5, citing his lower expected probability of success of 60% vs. 75% prior in its recently acquired CONTEPO for complicated urinary tract infection. The analyst says the program's main risk is an "imbalance of liver enzyme elevation while a slightly higher dose reduces read -through from about a 45-year post-market EU safety". Gerberry now believes that CONTEPO is a "niche opportunity", and lowers his peak sales view to $50M from $80M prior. The analyst also keeps his Buy rating on Nabriva on valuation as well as the opportunity for its two FDA action dates for lefamulin and CONTEPO in the second half of 2019.
09/07/18
MSCO
09/07/18
INITIATION
Target $8
MSCO
Overweight
Nabriva Therapeutics resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz resumed coverage of Nabriva Therapeutics with an Overweight rating and a $8 price target, stating that its "first-in-class" antibiotics lefamulin and Contepo both have approvable Phase 3 data. He believes at current levels Nabriva shares are pricing in a "worst case scenario" for both antibiotics, but he sees it as likely that Nabriva exceeds the low expectations. Lebowitz forecasts risk-adjusted 2025 sales for lefamulin and Contepo of $228M and $33M, respectively.
11/14/18
RHCO
11/14/18
NO CHANGE
Target $11
RHCO
Buy
Nabriva Therapeutics price target lowered to $11 from $16 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Nabriva Therapeutics to $11 after its Q3 earnings and the management's recent NDR presentation. The analyst says the company has disclosed that it has filed an NDA for Contepo in cUTI and plans to submit an NDA for lefamulin in community-acquired bacterial pneumonia with intention to price both drugs competitively to encourage their early use. Nash states that his lowered price target reflects the company's competitive pricing strategy but also keeps his Buy rating on Nabriva Therapeutics to reflect the potential of its treatments longer term.
01/28/19
HCWC
01/28/19
NO CHANGE
Target $9
HCWC
Buy
Nabriva Therapeutics price target lowered to $9 from $20 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered his price target for Nabriva Therapeutics to $9 but maintains a Buy rating on the shares following the company's analyst day. Nabriva is uniquely positioned to potentially launch two new classes of antibiotics in the U.S. by year end, Arce tells investors in a research note. The analyst says the company is approaching "several near-term value inflection points" towards its transition to a commercial stage biotech.

TODAY'S FREE FLY STORIES

DDAIF

Daimler AG

$0.00

(0.00%)

15:29
09/18/19
09/18
15:29
09/18/19
15:29
Hot Stocks
China's CATL to supply batteries for Daimler electric trucks »

Daimler Trucks &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

$26.30

-0.4 (-1.50%)

15:29
09/18/19
09/18
15:29
09/18/19
15:29
Options
Bullish calendar call spread with a delta hedge in Devon Energy Corp »

Bullish calendar call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

$26.32

-0.38 (-1.42%)

15:28
09/18/19
09/18
15:28
09/18/19
15:28
Options
- Bullish calendar call spread with a delta hedge in Devon Energy Corp »

- Bullish calendar call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$34.01

-0.27 (-0.79%)

15:27
09/18/19
09/18
15:27
09/18/19
15:27
Recommendations
Uber analyst commentary  »

Uber London operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$31.86

-0.51 (-1.58%)

15:25
09/18/19
09/18
15:25
09/18/19
15:25
Options
DXC Technology call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.69

-0.06 (-0.34%)

15:20
09/18/19
09/18
15:20
09/18/19
15:20
Hot Stocks
Shelton sees Cryoport becoming 'much broader' supply chain company »

Cryoport (CYRX) provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTB

M&T Bank

$158.78

0.66 (0.42%)

15:19
09/18/19
09/18
15:19
09/18/19
15:19
Hot Stocks
M&T Bank lowers prime lending rate to 5.0% from 5.25% »

Effective Thursday,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/18/19
09/18
15:17
09/18/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/18/19
09/18
15:16
09/18/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
09/18/19
09/18
15:15
09/18/19
15:15
General news
On the policy path: »

On the policy path: the…

SPY

SPDR S&P 500 ETF Trust

$299.06

-1.88 (-0.62%)

, SPX

S&P 500

$0.00

(0.00%)

15:11
09/18/19
09/18
15:11
09/18/19
15:11
General news
Fed Chair says not forecasting a recession »

Federal Reserve Chair…

SPY

SPDR S&P 500 ETF Trust

$299.06

-1.88 (-0.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$299.01

-1.93 (-0.64%)

, SPX

S&P 500

$0.00

(0.00%)

15:07
09/18/19
09/18
15:07
09/18/19
15:07
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell doesn't think…

SPY

SPDR S&P 500 ETF Trust

$299.01

-1.93 (-0.64%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTCH

Match Group

$77.00

-2.7 (-3.39%)

, IAC

IAC

$230.15

-6.58 (-2.78%)

15:02
09/18/19
09/18
15:02
09/18/19
15:02
Hot Stocks
Match Group names Thomas Gaissmaier as Chief Human Resources Officer »

Match Group (MTCH)…

MTCH

Match Group

$77.00

-2.7 (-3.39%)

IAC

IAC

$230.15

-6.58 (-2.78%)

FOX

Fox Corp.

$32.24

-0.57 (-1.74%)

DIS

Disney

$135.88

-0.36 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 10

    Oct

  • 24

    Oct

SPY

SPDR S&P 500 ETF Trust

$298.51

-2.43 (-0.81%)

, SPX

S&P 500

$0.00

(0.00%)

15:01
09/18/19
09/18
15:01
09/18/19
15:01
General news
Powell says trade policy among things weighing on outlook »

Fed Chair Powell said the…

SPY

SPDR S&P 500 ETF Trust

$298.51

-2.43 (-0.81%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRD

Friedman Industries

$6.12

-0.04 (-0.65%)

15:01
09/18/19
09/18
15:01
09/18/19
15:01
Hot Stocks
Friedman Industries names Michael J. Taylor president, CEO »

Friedman Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
09/18/19
09/18
15:00
09/18/19
15:00
General news
More from Powell: this is a time of difficult judgments and disparate perspectives »

More from Powell: this is…

14:50
09/18/19
09/18
14:50
09/18/19
14:50
General news
Powell in Q&A: on whether this rate cut is still a "mid-cycle adjustment? »

Powell in Q&A: on…

MLHR

Herman Miller

$44.20

-0.3 (-0.67%)

14:49
09/18/19
09/18
14:49
09/18/19
14:49
Options
Herman Miller options imply 12.7% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Oct

  • 22

    Oct

CYRX

Cryoport

$17.52

-0.23 (-1.30%)

14:47
09/18/19
09/18
14:47
09/18/19
14:47
Hot Stocks
Shelton sees 'bright future' ahead for Cryoport »

Cryoport (CYRX) provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$298.64

-2.3 (-0.76%)

, SPX

S&P 500

$0.00

(0.00%)

14:45
09/18/19
09/18
14:45
09/18/19
14:45
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says FOMC has…

SPY

SPDR S&P 500 ETF Trust

$298.64

-2.3 (-0.76%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:45
09/18/19
09/18
14:45
09/18/19
14:45
General news
Chair Powell at the podium: Powell said the Fed cut rates again »

Chair Powell at the…

FITB

Fifth Third

$28.24

0.05 (0.18%)

14:42
09/18/19
09/18
14:42
09/18/19
14:42
Hot Stocks
Fifth Third decreases prime lending rate to 5% »

Fifth Third Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SPY

SPDR S&P 500 ETF Trust

$298.73

-2.21 (-0.73%)

, SPX

S&P 500

$0.00

(0.00%)

14:41
09/18/19
09/18
14:41
09/18/19
14:41
General news
Fed Chair Powell says more rate cuts could be needed if economy weakens »

Asked if it remains his…

SPY

SPDR S&P 500 ETF Trust

$298.73

-2.21 (-0.73%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:40
09/18/19
09/18
14:40
09/18/19
14:40
General news
FOMC Forecast revisions »

FOMC Forecast revisions,…

SPY

SPDR S&P 500 ETF Trust

$298.88

-2.06 (-0.68%)

, SPX

S&P 500

$0.00

(0.00%)

14:38
09/18/19
09/18
14:38
09/18/19
14:38
General news
Fed Chair says additional signs seen of weakness abroad »

Federal Reserve Chair…

SPY

SPDR S&P 500 ETF Trust

$298.88

-2.06 (-0.68%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.